Fenylo-izopropylaminyl
Category
Fenylo-izopropylaminyl Brand names, Fenylo-izopropylaminyl Analogs
Fenylo-izopropylaminyl Brand Names Mixture
Adderall (amphetamine + dextroamphetamine) Adderall XR 10mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate) Adderall XR 15mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate) Adderall XR 20mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate) Adderall XR 25mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate) Adderall XR 30mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate) Adderall XR 5mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
Fenylo-izopropylaminyl Chemical_Formula
C9H13N
Fenylo-izopropylaminyl RX_link
http://www.rxlist.com/cgi/generic3/adderallxr.htm
Fenylo-izopropylaminyl fda sheet
Fenylo-izopropylaminyl msds (material safety sheet)
Fenylo-izopropylaminyl Synthesis Reference
U. S. Pat. 1,879,003, (1932)
Fenylo-izopropylaminyl Molecular Weight
135.206 g/mol
Fenylo-izopropylaminyl Melting Point
Volatizes slowly at room temperature
Fenylo-izopropylaminyl H2O Solubility
Slightly
Fenylo-izopropylaminyl State
Solid
Fenylo-izopropylaminyl LogP
1.799
Fenylo-izopropylaminyl Dosage Forms
Capsules
Fenylo-izopropylaminyl Indication
For treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children.
Fenylo-izopropylaminyl Pharmacology
Amphetamine and dextroamphetamine, non-catechloamine sypathomimetic agents, are used in combination to treat attention-deficit hyperactivity disorder (ADHD) or narcolepsy. Adderall consists of equivalent amounts of amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate.
Fenylo-izopropylaminyl Absorption
It forms easily absorbed molecules that are highly lipid soluble
Fenylo-izopropylaminyl Toxicity
LD50=180 mg/kg(s.c in rat). The most common presenting symptoms seen are agitation, hallucinations, suicidal behaviour, and chest pain.
Fenylo-izopropylaminyl Patient Information
Amphetamines may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or vehicles; the patient should therefore be cautioned accordingly.
Fenylo-izopropylaminyl Organisms Affected
Humans and other mammals